Physician profile
David Ring
NPI 1992017222
$4,779.98
in general payments reported to CMS, 2019-2025
28 companies · $1,137 in 2025
The $1,137 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,495 · 2020: $598 · 2021: $31.61 · 2022: $939 · 2023: $244 · 2024: $336 · 2025: $1,137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $908 · Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $907.63 |
| Food and Beverage | $809.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,753.65 | 2022-2025 | 1788 |
| Integra Lifesciences Corporation | $790.60 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Apollo Endosurgery US INC | $549.65 | 2020 | |
| Tei Biosciences INC | $408.08 | 2019 | |
| Organogenesis INC. | $197.33 | 2019-2024 | |
| Lemaitre Vascular, INC. | $155.26 | 2023 | Artegraft Vascular Graft |
| Kci USA, INC. | $135.82 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $122.48 | 2024-2025 | Voquezna |
| Kerecis Limited | $73.16 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Smith+Nephew, INC. | $53.22 | 2019 | |
| Polynovo North America LLC | $53.11 | 2024-2025 | Novosorb Btm |
| Endogastric Solutions, INC | $48.29 | 2020-2024 | Esophyx |
| Merck Sharp & Dohme LLC | $47.96 | 2019-2024 | Keytruda |
| Solventum Corporation | $44.75 | 2024-2025 | 3m Cavilon, Activ.A.C., Prevena |
| Csl Behring | $41.17 | 2021-2025 | Kcentra |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $39.92 | 2023-2025 | Savi Scout, Esophyx, Endomaxx Stent and Delivery System |
| Tela Bio, INC. | $37.32 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Convatec INC. | $29.70 | 2024 | |
| Mozarc Medical US LLC | $25.98 | 2023 | Chameleon |
| Innovation Technologies INC | $24.81 | 2020 | |
| Intuitive Surgical, INC. | $22.66 | 2024 | |
| Davol INC. | $22.20 | 2024 | Bard 3dmax Mesh |
| Mimedx Group, INC. | $18.80 | 2025 | |
| Baxter Healthcare | $18.21 | 2024 | |
| Mesh Suture INC | $18.01 | 2024 | |
| Janssen Pharmaceuticals, INC | $16.77 | 2019 | |
| Osiris Therapeutics INC. | $16.42 | 2019 | |
| Ethicon US, LLC | $14.65 | 2025 | Echelon Circular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.